Back to search
FDAFDA · Food and drugs·Recall number D-0769-2022

Preferred Pharmaceuticals, Inc. The Physician's Solution., Lansoprazole Delayed-Release Capsules, 15mg, Generic for Prevacid, 90-Count Bottle, Manufacturer: Dr Reddy's Laboratories Limited, NDC 68788-6390-09

Published April 20, 2022 · Recall initiated: March 28, 2022

Summary

FDA records drug Class II recall D-0769-2022, published April 20, 2022 and initiated March 28, 2022. Recalling firm: Preferred Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 791 bottles of 90 - Count; Lot: Lots: H0221R, D3021T, D2221J, D1321X, Exp.12/31/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Out of specification results observed in dissolution during long term stability testing.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Preferred Pharmaceuticals, Inc.
Distributor
Nationwide in the USA and CA.
Lot
Lots: H0221R, D3021T, D2221J, D1321X, Exp.12/31/2023.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Preferred Pharmaceuticals, Inc. The Physician's Solution., Lansoprazole Delayed-Release Capsules, 15mg, Generic for Prevacid, 90-Count Bottle, Manufacturer: Dr Reddy's Laboratories Limited, NDC 68788-6390-09 recalled?

Yes. FDA published recall D-0769-2022 on April 20, 2022. Reported hazard: Out of specification results observed in dissolution during long term stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit